+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Antibacterial Peptide Market by Product Type, Animal Type, Application, End User - Global Forecast to 2030- Product Image
Animal Antibacterial Peptide Market by Product Type, Animal Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Animal Antibacterial Peptide Market by Product Type, Animal Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904680
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Antibacterial Peptide Market grew from USD 4.06 billion in 2024 to USD 4.77 billion in 2025. It is expected to continue growing at a CAGR of 16.97%, reaching USD 10.42 billion by 2030.

Pioneering Sustainable Defenses in Animal Health

The animal health sector stands at a critical crossroads as the rise of antimicrobial resistance challenges conventional approaches to disease management. Antibacterial peptides, with their broad-spectrum efficacy and low propensity for resistance development, have emerged as a compelling alternative to traditional antibiotics. Growing regulatory constraints on antibiotic use in livestock, coupled with consumer demand for cleaner protein sources, have elevated these bioactive molecules from niche research subjects to mainstream solutions.

This executive summary distills the most salient developments shaping the animal antibacterial peptide market. It outlines the technological breakthroughs that are redefining efficacy profiles, examines the effects of evolving trade policies, and unpacks the complex mosaic of market segments. By weaving together regional dynamics and corporate strategies, it delivers a cohesive narrative that underscores both immediate opportunities and long-term imperatives for stakeholders across the value chain.

Emergence of Novel Mechanisms Driving Market Evolution

In recent years, breakthroughs in peptide engineering have unlocked novel mechanisms of action that extend beyond simple bacterial cell disruption. Advances in high-throughput screening and computational modeling now enable rapid identification of peptide sequences optimized for target specificity and stability under feed processing conditions. This convergence of data science with biotechnology has accelerated time-to-market for next-generation candidates.

Parallel to these scientific gains, regulatory bodies in key geographies are enacting stricter guidelines on antibiotic residues in animal products, further incentivizing the switch to peptide-based solutions. The shift toward precision nutrition and integrated health management is also reshaping procurement practices, as farms and feed mills increasingly demand turnkey formulations that blend growth promotion with prophylactic safeguards.

Moreover, collaborations between academic labs and industry partners are fostering ecosystems of open innovation. Public-private consortia are pooling resources to validate safety and efficacy in real-world settings, setting the stage for more predictable regulatory pathways and scalable manufacturing processes.

Navigating US Tariff Adjustments and Their Ripple Effects

The introduction of new United States tariffs in 2025 on peptide raw materials and finished products has introduced an additional layer of complexity for manufacturers and end users. Input costs have risen as suppliers recalibrate their logistics networks to mitigate levies, prompting some producers to reassess their sourcing strategies and explore domestic peptide synthesis facilities.

Feed integrators and pharmaceutical developers have responded by negotiating long-term supply agreements to lock in favorable pricing and ensure continuity. In parallel, a segment of the market has turned to regional partners to diversify risk and reduce dependency on transpacific shipping lanes. This has catalyzed investment in local production capacity, particularly within North American biotechnology clusters.

While these adjustments have exerted upward pressure on sale prices, they have also stimulated process innovation aimed at improving yield and reducing waste. Companies that have adopted lean manufacturing principles and advanced purification techniques are better positioned to absorb tariff‐related cost increases without passing them fully onto end users.

Unveiling Market Opportunities Through Comprehensive Segmentation Analysis

A granular view of the market reveals distinct dynamics across product categories. Naturally derived peptides often command a premium based on their perceived holistic benefits, yet synthetic variants-classified by long, medium, and short chain lengths-are gaining ground for their customizable properties and scalability. Medium-chain synthetic peptides have particularly resonated with formulators seeking an optimal balance between efficacy and cost.

The animal types served by these solutions span aquaculture, companion care, livestock, and poultry. Within aquaculture, demand for antiviral peptides in fish and antibacterial protections in shrimp has surged, driven by stock density challenges. Companion animals benefit from topical and systemic applications, while livestock segments focused on bovine, caprine, and swine have adopted feed-based delivery of peptides to promote gut health and minimize growth setbacks.

Applications bifurcate into growth promotion, prophylactic use, and targeted therapeutics. Disease prevention protocols leverage peptides as vaccine adjuvants and prebiotic alternatives to traditional antibiotics, reducing the incidence of outbreaks on commercial operations. Therapeutic applications address infection treatment in acute scenarios and skin disease interventions, improving recovery times and animal welfare outcomes.

End users encompass aquaculture farms, feed manufacturers, research institutes, and veterinary clinics. Feed formulators-spanning aquafeed and livestock feed-integrate peptides into compound rations to streamline distribution. Research entities from academic institutes to biotech companies drive discovery pipelines, while veterinary practices tailor peptide therapies to both large and small animal patients.

Regional Dynamics Shaping Competitive Landscapes

Market behavior diverges significantly across global regions. In the Americas, vertically integrated producers leverage established feed mill networks and progressive regulatory frameworks to accelerate peptide adoption. Latin American markets are following suit, buoyed by rising meat consumption and government initiatives to curb antibiotic misuse.

Europe, the Middle East, and Africa present a mixed landscape. Stringent residue limits in the European Union and the rollout of antibiotic-reduction mandates have created fertile ground for peptide innovations, especially in specialized companion animal products. Meanwhile, certain Middle Eastern markets are investing in aquaculture infrastructure, and key African nations are piloting peptide applications as part of broader livestock health improvement programs.

Asia-Pacific leads in manufacturing capacity and consumption volume. Government subsidies for aquafeed modernization in Southeast Asia have reinforced demand for antimicrobial peptides in shrimp and fish. In East Asia, rapid urbanization and rising disposable incomes drive companion animal care spend, fueling interest in premium peptide-based therapies. Across the region, emerging economies are moving swiftly to adopt peptides as antibiotics face tightening regulatory scrutiny.

Leading Innovators Forging the Future of Antibacterial Solutions

Industry leaders are forging ahead with differentiated strategies to capture market share. Established life science firms have expanded their peptide portfolios through acquisitions of niche biotech startups, enabling them to offer end-to-end solutions from R&D through commercial scale-up. These incumbents emphasize robust regulatory affairs teams to expedite approvals across multiple territories.

Meanwhile, specialized producers focus on developing proprietary peptide libraries and advanced encapsulation technologies that extend shelf life and enhance bioavailability. Collaborations with feed manufacturers have generated co-branded products that integrate peptides into existing distribution channels, reducing barriers to trial adoption.

Academic spin-outs are also emerging as agile competitors. Armed with cutting-edge discoveries in synthetic biology, these ventures partner with contract development and manufacturing organizations to accelerate bench-to-market timelines. Their nimble operations and focused pipelines position them to disrupt legacy players in select high-growth niches.

Strategic Imperatives for Capitalizing on Market Momentum

To capitalize on accelerating demand, industry leaders should prioritize strategic investments in chain length optimization. By fine-tuning peptide sequences to target specific pathogens and host systems, developers can enhance efficacy while minimizing off-target effects. Joint ventures with specialized feed mills can streamline pilot programs and reinforce adoption among end users.

Strengthening compliance functions will be critical as regulators worldwide harmonize guidelines on antibiotic alternatives. Companies that engage proactively with policy makers can shape favorable frameworks for peptide applications, ensuring faster market access and reduced approval risks.

Geographic expansion into high-growth aquaculture and companion animal markets requires localized partnerships. Establishing regional manufacturing or licensing agreements can mitigate logistical costs and tariffs while fostering trust with distributors and practitioners. At the same time, leveraging genomic insights to identify emerging disease threats can inform adaptive pipeline planning and early-stage development priorities.

Finally, cultivating open innovation ecosystems-through research consortia and academic alliances-will unlock cross-disciplinary expertise and shared infrastructure. This cooperative approach not only accelerates validation efforts but also disperses the financial risk inherent to complex peptide discovery.

Rigorous Framework Combining Quantitative and Qualitative Insights

This analysis integrates primary and secondary research to deliver a robust market perspective. Primary inputs include in-depth interviews with R&D heads, regulatory specialists, feed formulators, and veterinary practitioners. These conversations illuminated real-world challenges and validated emerging use cases for peptide interventions.

Secondary research drew upon peer-reviewed journals, patent databases, trade association reports, and policy filings. Data triangulation across these sources ensured accuracy and consistency, with discrepancies reconciled through follow-up inquiries and expert workshops.

The segmentation framework was defined to capture the full spectrum of market variability, from product type and animal species to application categories and end-user profiles. Regional categorization encompassed the Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting both consumption patterns and manufacturing hubs.

This methodology emphasizes qualitative insights and strategic interpretation over predictive forecasting. By focusing on validated trends and operational considerations, it equips stakeholders with actionable intelligence to inform portfolio planning, partnership decisions, and regulatory engagement.

Charting the Course Toward a Resilient Peptide Ecosystem

The animal antibacterial peptide market is poised for significant transformation as technological advancements, policy shifts, and evolving consumer preferences converge. Stakeholders who navigate tariff headwinds, harness segmentation insights, and capitalize on regional nuances will secure competitive advantages in an increasingly crowded field.

Innovation pipelines that leverage synthetic design alongside naturally derived scaffolds will deliver diversified offerings tailored to specific species and use cases. Concurrently, strategic collaborations and agile production models will drive efficiency and responsiveness, ensuring that peptide solutions remain accessible and cost-effective.

Ultimately, the success of antibacterial peptides in animal health hinges on a coordinated effort across industry, academia, and regulatory bodies. By adhering to the strategic imperatives outlined herein and embracing an open innovation ethos, organizations can chart a course toward a more resilient, sustainable, and profitable future.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Naturally Derived Peptide
    • Synthetic Peptide
      • Long Chain
      • Medium Chain
      • Short Chain
  • Animal Type
    • Aquaculture
      • Fish
      • Shrimp
    • Companion Animals
    • Livestock
      • Bovine
      • Caprine
      • Swine
    • Poultry
  • Application
    • Growth Promotion
    • Prophylactic
      • Disease Prevention
      • Vaccination Adjuvant
    • Therapeutic
      • Infection Treatment
      • Skin Disease Treatment
  • End User
    • Aquaculture Farms
    • Feed Manufacturers
      • Aquafeed
      • Livestock Feed
    • Research Institutes
      • Academic Institute
      • Biotech Company
    • Veterinary Clinics
      • Large Animal Practice
      • Small Animal Practice
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Neogen Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Animal Antibacterial Peptide Market, by Product Type
8.1. Introduction
8.2. Naturally Derived Peptide
8.3. Synthetic Peptide
8.3.1. Long Chain
8.3.2. Medium Chain
8.3.3. Short Chain
9. Animal Antibacterial Peptide Market, by Animal Type
9.1. Introduction
9.2. Aquaculture
9.2.1. Fish
9.2.2. Shrimp
9.3. Companion Animals
9.4. Livestock
9.4.1. Bovine
9.4.2. Caprine
9.4.3. Swine
9.5. Poultry
10. Animal Antibacterial Peptide Market, by Application
10.1. Introduction
10.2. Growth Promotion
10.3. Prophylactic
10.3.1. Disease Prevention
10.3.2. Vaccination Adjuvant
10.4. Therapeutic
10.4.1. Infection Treatment
10.4.2. Skin Disease Treatment
11. Animal Antibacterial Peptide Market, by End User
11.1. Introduction
11.2. Aquaculture Farms
11.3. Feed Manufacturers
11.3.1. Aquafeed
11.3.2. Livestock Feed
11.4. Research Institutes
11.4.1. Academic Institute
11.4.2. Biotech Company
11.5. Veterinary Clinics
11.5.1. Large Animal Practice
11.5.2. Small Animal Practice
12. Americas Animal Antibacterial Peptide Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Animal Antibacterial Peptide Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Animal Antibacterial Peptide Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Elanco Animal Health Incorporated
15.3.3. Merck & Co., Inc.
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Vetoquinol S.A.
15.3.8. Phibro Animal Health Corporation
15.3.9. Dechra Pharmaceuticals PLC
15.3.10. Neogen Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET MULTI-CURRENCY
FIGURE 2. ANIMAL ANTIBACTERIAL PEPTIDE MARKET MULTI-LANGUAGE
FIGURE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY NATURALLY DERIVED PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LONG CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MEDIUM CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHORT CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CAPRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VACCINATION ADJUVANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY INFECTION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SKIN DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUAFEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ACADEMIC INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY BIOTECH COMPANY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LARGE ANIMAL PRACTICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SMALL ANIMAL PRACTICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 77. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 79. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 80. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 82. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 83. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 85. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 94. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 95. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 153. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 155. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 156. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 159. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 160. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 163. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 165. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 167. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 168. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 171. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 186. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 188. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 189. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 191. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 192. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 194. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 195. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 198. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 201. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 203. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 204. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 244. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 246. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 247. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 249. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 251. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 252. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 255. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 268. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 270. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 271. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 272. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 273. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 275. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 276. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 278. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 279. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 282. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 283. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 284. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 285. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 287. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 288. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 291. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 201

Companies Mentioned

The companies profiled in this Animal Antibacterial Peptide market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Neogen Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.42 Billion
Compound Annual Growth Rate16.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Animal Antibiotics & Antimicrobials Market by Class, Animal Species, Administration Route, Formulation, Distribution Channel - Global Forecast to 2030 - Product Image

Animal Antibiotics & Antimicrobials Market by Class, Animal Species, Administration Route, Formulation, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Application Mode, End Use, Formulation, Sales Channel - Global Forecast to 2030 - Product Image

Non-Therapeutic Antibiotics for Food Animals Market by Animal Type, Product Type, Application Mode, End Use, Formulation, Sales Channel - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Animal Antibiotics and Antimicrobials Market Report 2025 - Product Image

Animal Antibiotics and Antimicrobials Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.